Emerging therapeutics for primary peritoneal cancer

Brian M Slomovitz, Michael J Worley, Maurie Markman, Robert L Coleman

Open source

DOI: 10.1517/14728214.2011.526600
Published: 2011-02-25
Container: Expert Opinion on Emerging Drugs
Publisher: Informa Healthcare
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1517/14728214.2011.526600,
  title = {Emerging therapeutics for primary peritoneal cancer},
  author = {Brian M Slomovitz and Michael J Worley and Maurie Markman and Robert L Coleman},
  year = {2011},
  journal = {Expert Opinion on Emerging Drugs},
  doi = {10.1517/14728214.2011.526600},
  url = {https://doi.org/10.1517/14728214.2011.526600}
}

RIS

TY  - JOUR
TI  - Emerging therapeutics for primary peritoneal cancer
AU  - Brian M Slomovitz
AU  - Michael J Worley
AU  - Maurie Markman
AU  - Robert L Coleman
PY  - 2011
JO  - Expert Opinion on Emerging Drugs
DO  - 10.1517/14728214.2011.526600
UR  - https://doi.org/10.1517/14728214.2011.526600
ER  -

APA

Slomovitz, B. M., Worley, M. J., Markman, M., & Coleman, R. L. (2011). Emerging therapeutics for primary peritoneal cancer. Expert Opinion on Emerging Drugs. https://doi.org/10.1517/14728214.2011.526600

Source records

crossref · retrieved 2026-09-27T02:29:31.026Z